Dose-Dependent Effects of a Novel Selective EP(4) Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model

por Vater, Corina, Mehnert, Elisabeth, Bretschneider, Henriette, Bolte, Julia, Findeisen, Lisa, Matuszewski, Lucas-Maximilian, Zwingenberger, Stefan
Publicado 2021

Cell spheroids are as effective as single cells suspensions in the treatment of critical-sized bone defects

por Findeisen, Lisa, Bolte, Julia, Vater, Corina, Petzold, Cathleen, Quade, Mandy, Müller, Lars, Goodman, Stuart B., Zwingenberger, Stefan
Publicado 2021

Treatment of Critical-Size Femoral Bone Defects with Chitosan Scaffolds Produced by a Novel Process from Textile Engineering

por Zwingenberger, Bruno, Vater, Corina, Bell, Roland L., Bolte, Julia, Mehnert, Elisabeth, Brünler, Ronny, Aibibu, Dilbar, Zwingenberger, Stefan
Publicado 2021

A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein–2 and zoledro...

por Raina, Deepak Bushan, Matuszewski, Lucas-Maximilian, Vater, Corina, Bolte, Julia, Isaksson, Hanna, Lidgren, Lars, Tägil, Magnus, Zwingenberger, Stefan
Publicado 2020

Treatment of Critical Size Femoral Bone Defects with Biomimetic Hybrid Scaffolds of 3D Plotted Calcium Phosphate Cement and Mineralized Collagen Matrix

por Culla, Anna Carla, Vater, Corina, Tian, Xinggui, Bolte, Julia, Ahlfeld, Tilman, Bretschneider, Henriette, Pape, Alexander, Goodman, Stuart B., Gelinsky, Michael, Zwingenberger, Stefan
Publicado 2022